menu

Putting the Puzzle Together in Axial Disease: Assessment and Management of Axial Features in Patients With axSpA and axPsA

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
x
Hello, there.

Disclosures

This presentation is sponsored by Novartis Medical Affairs, and the speakers have been compensated for their time.

Christopher T. Ritchlin, MD, MPH

  • Research: UCB, AbbVie, Amgen
  • Consultant: UCB, AbbVie, Amgen, Janssen, Novartis, Pfizer, Lilly

Atul Deodhar, MD, MRCP

  • Research grants: Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Novartis, Pfizer, and UCB
  • Member of advisory boards and/ or consultant: AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen, Novartis, Pfizer, and UCB

Philip J. Mease, MD, MACR

  • Consultant: AbbVie, Amgen, Bristol Myers Squibb, Celegene, Corrona, Eli Lilly, Janssen, Merck, Novartis, Pfizer, Sun, and UCB
  • Speaker: AbbVie, Amgen, Bristol Myers Squibb, Celegene, Genentech, Janssen, Novartis, Pfizer, and UCB
  • Research grants: AbbVie, Amgen, Bristol Myers Squibb, Celegene, Eli Lilly, Janssen, Novartis, Pfizer, Sun, and UCB

Alexis Ogdie-Beatty, MD, MSCE

  • Consultant: AbbVie, Amgen, Bristol Myers Squibb, Celgene, Corrona, Lilly, Novartis, Pfizer, Takeda
  • Research grants: Novartis, Pfizer, Forward/National Databank for Rheumatic Diseases, NIH/NIAMS, Rheum Research Foundation
Read Full Program Description
CONTINUE TO PROGRAM

Putting the Puzzle Together in Axial Disease: Assessment and Management of Axial Features in Patients With axSpA and axPsA

10 chapters
Play All
Program Information
Chapters
Recommended

Program Information

Chapter 1
ReachMD Healthcare Image
RestartResume

Listen in as medical experts have a conversation on the diagnostic delays in spondyloarthritis (SpA) and what can be done to address the gaps.

  • Sponsored by

  • Overview

    Can you put the puzzle together in axial spondyloarthritis (axSpA) and axial psoriatic arthritis (axPsA)? 

    Axial involvement is an important feature in patients with SpA and PsA, and this manifestation has various similarities and differences between both diseases.1,2 Recognizing and assessing the unique presentation of axPsA and axSpA is critical to improve the outcomes in our patients.

    Listen in to a discussion panel moderated by Christopher T. Ritchlin, MD with Atul Deodhar, MD, Philip Mease, MD, and Alexis Ogdie-Beatty, MD, as they discuss current diagnostic challenges and new insights on the assessment of axial features.

    This presentation is sponsored by Novartis Medical Affairs and all speakers have been compensated for their time.

    References

    1. Feld J, Chandran V, Haroon N, Inman R, Gladman D. Axial disease in psoriatic arthritis and ankylosing spondylitis: A critical comparison. Nat Rev Rheumatol. 2018;14(6):363-371. doi:10.1038/s41584-018-0006-8
    2. Helliwell PS. Axial disease in psoriatic arthritis. Rheumatology. 2019:1-3. doi:10.1093/rheumatology/kez629

    3/21     M-XAT-1399851​

Programs 9/20/21